Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.

Autor: Ciceri F; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: ciceri.fabio@hsr.it., Castagna A; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Rovere-Querini P; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., De Cobelli F; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Ruggeri A; IRCCS San Raffaele Scientific Institute, Milan, Italy., Galli L; IRCCS San Raffaele Scientific Institute, Milan, Italy., Conte C; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., De Lorenzo R; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Poli A; IRCCS San Raffaele Scientific Institute, Milan, Italy., Ambrosio A; IRCCS San Raffaele Scientific Institute, Milan, Italy., Signorelli C; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Bossi E; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Fazio M; IRCCS San Raffaele Scientific Institute, Milan, Italy., Tresoldi C; IRCCS San Raffaele Scientific Institute, Milan, Italy., Colombo S; IRCCS San Raffaele Scientific Institute, Milan, Italy., Monti G; IRCCS San Raffaele Scientific Institute, Milan, Italy., Fominskiy E; IRCCS San Raffaele Scientific Institute, Milan, Italy., Franchini S; IRCCS San Raffaele Scientific Institute, Milan, Italy., Spessot M; IRCCS San Raffaele Scientific Institute, Milan, Italy., Martinenghi C; IRCCS San Raffaele Scientific Institute, Milan, Italy., Carlucci M; IRCCS San Raffaele Scientific Institute, Milan, Italy., Beretta L; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Scandroglio AM; IRCCS San Raffaele Scientific Institute, Milan, Italy., Clementi M; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Locatelli M; IRCCS San Raffaele Scientific Institute, Milan, Italy., Tresoldi M; IRCCS San Raffaele Scientific Institute, Milan, Italy., Scarpellini P; IRCCS San Raffaele Scientific Institute, Milan, Italy., Martino G; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Bosi E; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Dagna L; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Lazzarin A; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Landoni G; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy., Zangrillo A; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Milan, Italy.
Jazyk: angličtina
Zdroj: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2020 Aug; Vol. 217, pp. 108509. Date of Electronic Publication: 2020 Jun 12.
DOI: 10.1016/j.clim.2020.108509
Abstrakt: Background: National health-system hospitals of Lombardy faced a heavy burden of admissions for acute respiratory distress syndromes associated with coronavirus disease (COVID-19). Data on patients of European origin affected by COVID-19 are limited.
Methods: All consecutive patients aged ≥18 years, coming from North-East of Milan's province and admitted at San Raffaele Hospital with COVID-19, between February 25th and March 24th, were reported, all patients were followed for at least one month. Clinical and radiological features at admission and predictors of clinical outcomes were evaluated.
Results: Of the 500 patients admitted to the Emergency Unit, 410 patients were hospitalized and analyzed: median age was 65 (IQR 56-75) years, and the majority of patients were males (72.9%). Median (IQR) days from COVID-19 symptoms onset was 8 (5-11) days. At hospital admission, fever (≥ 37.5 °C) was present in 67.5% of patients. Median oxygen saturation (SpO2) was 93% (range 60-99), with median PaO 2 /FiO 2 ratio, 267 (IQR 184-314). Median Radiographic Assessment of Lung Edema (RALE) score was 9 (IQR 4-16). More than half of the patients (56.3%) had comorbidities, with hypertension, coronary heart disease, diabetes and chronic kidney failure being the most common. The probability of overall survival at day 28 was 66%. Multivariable analysis showed older age, coronary artery disease, cancer, low lymphocyte count and high RALE score as factors independently associated with an increased risk of mortality.
Conclusion: In a large cohort of COVID-19 patients of European origin, main risk factors for mortality were older age, comorbidities, low lymphocyte count and high RALE.
(Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: